[go: up one dir, main page]

TW202529803A - 用於治療伴有多血管炎的嗜酸性球性肉芽腫病的ＩＬ－５Ｒ－α抗體 - Google Patents

用於治療伴有多血管炎的嗜酸性球性肉芽腫病的ＩＬ－５Ｒ－α抗體

Info

Publication number
TW202529803A
TW202529803A TW113135872A TW113135872A TW202529803A TW 202529803 A TW202529803 A TW 202529803A TW 113135872 A TW113135872 A TW 113135872A TW 113135872 A TW113135872 A TW 113135872A TW 202529803 A TW202529803 A TW 202529803A
Authority
TW
Taiwan
Prior art keywords
weeks
antibody
patient
antigen
administration
Prior art date
Application number
TW113135872A
Other languages
English (en)
Chinese (zh)
Inventor
伊莉莎白 鄧肯
蘇菲亞 尼坎德
吉娜 狄安傑羅
喬 莉娜 博爾傑森
Original Assignee
瑞典商阿斯特捷利康公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑞典商阿斯特捷利康公司 filed Critical 瑞典商阿斯特捷利康公司
Publication of TW202529803A publication Critical patent/TW202529803A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW113135872A 2023-09-21 2024-09-20 用於治療伴有多血管炎的嗜酸性球性肉芽腫病的ＩＬ－５Ｒ－α抗體 TW202529803A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202363584453P 2023-09-21 2023-09-21
US63/584,453 2023-09-21
US202363597634P 2023-11-09 2023-11-09
US63/597,634 2023-11-09
US202463648325P 2024-05-16 2024-05-16
US63/648,325 2024-05-16

Publications (1)

Publication Number Publication Date
TW202529803A true TW202529803A (zh) 2025-08-01

Family

ID=93119819

Family Applications (1)

Application Number Title Priority Date Filing Date
TW113135872A TW202529803A (zh) 2023-09-21 2024-09-20 用於治療伴有多血管炎的嗜酸性球性肉芽腫病的ＩＬ－５Ｒ－α抗體

Country Status (2)

Country Link
TW (1) TW202529803A (fr)
WO (1) WO2025062362A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
CA2205007C (fr) 1995-09-11 2010-12-14 Masamichi Koike Anticorpos de la chaine alpha du recepteur de l'interleukine 5 humaine

Also Published As

Publication number Publication date
WO2025062362A1 (fr) 2025-03-27

Similar Documents

Publication Publication Date Title
EP3703818B1 (fr) Antagoniste d'il-4r pour son utilisation dans le traitement ou la prévention de l'asthme
RS58091B1 (sr) Metode za tretiranje ili prevenciju astme davanjem antagonista il-4r
JP7164530B2 (ja) Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法
CN118924895A (zh) 用于癌症治疗的结合her2、nkg2d和cd16的多特异性结合蛋白的药物制剂和剂量方案
JP2024001125A (ja) Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
TW202417482A (zh) 治療補體介導疾病的方法
JP2021523881A (ja) リゲリズマブを使用して慢性特発性蕁麻疹を治療する方法
CN106573975A (zh) 抗il4‑il13双特异性抗体
WO2017221174A1 (fr) Méthodes de traitement du vitiligo à l'aide d'anticorps de l'interleukine-17 (il -17)
JP2023505215A (ja) Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法
JP2022549218A (ja) 抗トリプターゼ抗体の投薬
JP7410256B2 (ja) 化膿性汗腺炎の治療のための汎ｅｌｒ＋ｃｘｃケモカイン抗体
TW202529803A (zh) 用於治療伴有多血管炎的嗜酸性球性肉芽腫病的ＩＬ－５Ｒ－α抗體
CN118524849A (zh) 用于治疗多血管炎、嗜酸性粒细胞增多综合症、伴有鼻息肉的慢性鼻窦炎嗜酸性粒细胞增多综合症(crswnp)或不伴有鼻息肉慢性鼻窦炎(crssnp)的白细胞介素5结合蛋白给药方案
JP2024517796A (ja) 抗ｂａｆｆｒ抗体を使用するループス腎炎の治療
TW202206457A (zh) 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體
US20250313618A1 (en) Methods of treating giant cell arteritis using Interleukin-17 (IL-17) Antagonists
JP2024542777A (ja) 多発血管炎、好酸球増多症候群、好酸球増多症候群、鼻ポリープを伴う慢性副鼻腔炎（ｃｒｓｗｎｐ）又は鼻ポリープを伴わない慢性副鼻腔炎（ｃｒｓｓｎｐ）の処置における使用のためのインターロイキン５結合タンパク質投与レジメン
JP6923594B2 (ja) Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法
WO2018158741A1 (fr) Modification de la maladie du psoriasis suite à un traitement à long terme avec un antagoniste de l'il-17
WO2025257781A1 (fr) Traitement de la sclérose systémique à l'aide d'anticorps anti-baff-r
WO2024153182A1 (fr) Utilisation d'un anticorps bispécifique anti-pvrig/anti-tigit dans le traitement de tumeurs malignes
JP2024500912A (ja) インターロイキン５結合タンパク質の投与レジメン
WO2021111377A2 (fr) Procédés de traitement de lichen plan à l'aide d'antagonistes de l'interleukine 17 (il-17)
JP2024516019A (ja) 抗ｂａｆｆｒ抗体を使用する全身性エリテマトーデスのための治療